|
1
|
Halim AS, Emami A, Salahshourifar I and
Kannan TP: Keloid scarring: Understanding the genetic basis,
advances and prospects. Arch Plast Surg. 3:184–189. 2012.
View Article : Google Scholar
|
|
2
|
Shih B and Bayat A: Genetics of keloid
scarring. Arch Dermatol Res. 5:319–339. 2010. View Article : Google Scholar
|
|
3
|
Chen W, Fu X, Sun X, Sun T, Zhao Z and
Sheng Z: Analysis of differentially expressed genes in keloids and
normal skin with cDNA microarray. J Surg Res. 113:208–216. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Russell SB, Russell JD, Trupin KM, Gayden
AE, Opalenik SR, Nanney LB, Broquist AH, Raju L and Williams SM:
Epigenetically altered wound healing in keloid fibroblasts. J
Invest Dermatol. 130:2489–2496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stahlhut M, Bertelsen M, Hoyer-Hansen M,
Svendsen N, Eriksson AH, Lord JM, Scheel-Toellner D, Young SP and
Zibert JR: Ingenol mebutate: Induced cell death patterns in normal
and cancer epithelial cells. J Drugs Dermatol. 11:1181–1192.
2012.PubMed/NCBI
|
|
6
|
De Felice B, Guida M, Boccia L and Nacca
M: Ingenol mebutate treatment in keloids. BMC Res Notes. 8:4662015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Navarro F and Lieberman J: miR-34 and p53:
New insights into a complex functional relationship. PLoS One.
10:e01327672015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tarasov V, Jung P, Verdoodt B, Lodygin D,
Epanchintsev A, Menssen A, Meister G and Hermeking H: Differential
regulation of microRNAs by p53 revealed by massively parallel
sequencing: miR-34a is a p53 target that induces apoptosis and
G1-arrest. Cell Cycle. 3:1586–1593. 2007. View Article : Google Scholar
|
|
9
|
Hermeking H: The miR-34 family in cancer
and apoptosis. Cell Death Differ. 17:193–199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu X, Fortin K and Mourelatos Z:
MicroRNAs: Biogenesis and molecular functions. Brain Pathol.
18:113–121. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Beermann J, Piccoli MT, Viereck J and Thum
T: Non-coding RNAs in development and disease: Background,
mechanisms and therapeutic approaches. Physiol Rev. 96:1297–1325.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ebert MS and Sharp PA: Roles for microRNAs
in conferring robustness to biological processes. Cell.
149:515–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
De Felice B, Guida M, Guida M, Coppola C,
De Mieri G and Cotrufo R: A miRNA signature in leukocytes from
sporadic amyotrophic lateral sclerosis. Gene. 508:35–40. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rukov JL and Shomron N: MicroRNA
pharmacogenomics: Post-transcriptional regulation of drug response.
Trends Mol Med. 17:412–423. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koturbash I, Tolleson WH, Guo L, Yu D,
Chen S, Hong H, Mattes W and Ning B: MicroRNAs as pharmacogenomics
biomarkers for drug efficacy and drug safety assessment. Biomark
Med. 9:1153–1176. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shomron N: MicroRNAs and pharmacogenomics.
Pharmaco-genomics. 11:629–632. 2010.
|
|
17
|
Lim IJ, Phan TT, Song C, Tan WT and
Longaker MT: Investigation of the influence of keloid-derived
keratinocytes on fibroblast growth and proliferation in vitro.
Plastic Reconstr Surg. 107:797–808. 2001. View Article : Google Scholar
|
|
18
|
He Y, Chevillet JR, Liu G, Kim TK and Wang
K: The effects of microRNA on the absorption, distribution,
metabolism and excretion of drugs. Br J Pharmacol. 172:2733–2747.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chang TC, Wentzel EA, Kent OA,
Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M,
Ferlito M, Lowenstein CJ, et al: Transactivation of miR-34a by p53
broadly influences gene expression and promotes apoptosis. Mol
Cell. 26:745–752. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Raver-Shapira N, Marciano E, Meiri E,
Spector Y, Rosenfeld N, Moskovits N, Bentwich Z and Oren M:
Transcriptional activation of miR-34a contributes to p53-mediated
apoptosis. Mol Cell. 26:731–743. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Oren M: Decision making by p53: Life,
death and cancer. Cell Death Differ. 10:431–442. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rokavec M, Li H, Jiang L and Hermeking H:
The p53/miR-34 axis in development and disease. J Mol Cell Biol.
6:214–230. 2014. View Article : Google Scholar : PubMed/NCBI
|
